Sou Hu Cai Jing·2025-05-30 21:51Summary of Key Points Core Viewpoint - *ST Suwu is under investigation by the China Securities Regulatory Commission (CSRC) for potential financial misconduct, which may lead to mandatory delisting due to serious violations [1] Company Announcement Summary - As of May 30, 2025, *ST Suwu's stock price closed at 2.72 yuan, up 1.87% from the previous week, with a total market capitalization of 1.937 billion yuan, ranking 148th out of 150 in the chemical pharmaceutical sector and 4933rd out of 5146 in the A-share market [1] - The company has been placed under investigation by the CSRC, which may result in mandatory delisting if significant violations are confirmed [1] - The 2024 financial report received an "unable to express an opinion" from the auditing firm, indicating potential financial delisting risks, and the stock has been flagged for delisting risk by the Shanghai Stock Exchange [1] - Internal controls for the 2024 financial report also received an "unable to express an opinion," and there are issues with non-operational fund occupation by related parties [1] - The chairman of the company is under investigation for violations related to information disclosure, and the company is committed to keeping investors informed about the developments [1] - Despite these issues, the company's daily operations remain normal, and there have been no significant changes in the market environment or industry policies [1]